Combinatorial Chemistry Consortium

The Combinatorial Chemistry Consortium (founded in 1996 directed out of Molecular Simulations, Inc.)... 

Profile Founded in 1984, this privately held company provides molecular modeling and simulation software for both life and materials science research. The company employs more than 280 people (approximately half of whom are Ph.D. scientists) it operates sales offices around the world and a research and development facility in Cambridge, England. MSI s Combinatorial Chemistry Consortium addresses the full scope of the combinatorial chemistry process and is focused on maximizing the productivity of library design and analysis. In February 1998, Molecular Simulations Inc. and Pharmacopeia Inc. announced a definitive agreement whereby Pharmacopeia will acquire all of the outstanding stock of MSI. The transaction is expected to be completed in the second quarter of 1998 upon completion MSI will become a wholly owned subsidiary. 

Profile Founded in late 1996, SIDDCO is a privately held company that is based on a mission to integrate and apply state-of-the-art approaches to drug discovery. SIDDCO is a combinatorial chemistry consortium that pools the resources of the consortium partners to fund a critical mass of chemists to develop the combinatorial chemistry technology database and methodologies. SIDDCO provides a dedicated team of medicinal chemists to each partner to exploit the shared technology and satisfy the drug discovery and drug optimization needs of specific projects. 

The Diversity Biotechnology Consortium The Combinatorial Chemistry Consortium... 

Table 4 The Consortium Business Format in Combinatorial Chemistry... 

---